Centralized Virtual SBIRT for Pediatric Primary Care
Virtual SBIRT for Pediatric Primary Care: Increasing Access to Screening, Brief Intervention and Referral to Treatment for Alcohol and Other Drug Use Via Telehealth
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Stacy A Sterling, DrPH, MSW
- Phone Number: 5105028619
- Email: Stacy.A.Sterling@kp.org
Study Contact Backup
- Name: Melanie Jackson-Morris
- Phone Number: 9162040137
- Email: melanie.j.jackson-morris@kp.org
Study Locations
-
-
California
-
Pleasanton, California, United States, 94588
- Recruiting
- Kaiser Permanente Division of Research
-
Contact:
- Melanie Jackson-Morris
- Phone Number: 9162040137
- Email: melanie.j.jackson-morris@kp.org
-
Contact:
- Stacy A Sterling, DrPH, MSW
- Phone Number: 510-502-8619
- Email: Stacy.A.Sterling@kp.org
-
Principal Investigator:
- Stacy A Sterling, DrPH, MSW
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
• The sample will include all adolescents aged 12 through 17 years seen for a Well Visit, who are at risk of AOD use disorder defined as endorsing monthly or more frequent AOD use OR any AOD use and past-two-week depressive symptoms or suicidality.
Exclusion Criteria:
• N/A - all adolescents with a Well Visit are eligible
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Usual Care/Traditional SBIRT
Clinics where appointment-based brief interventions are delivered by a behavioral health clinician assigned to the clinic (Traditional SBIRT arm)
|
Brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician
|
|
Experimental: CV SBIRT
Clinics where brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician (CV-SBIRT arm)
|
Brief interventions are delivered virtually by video or telephone by a centralized behavioral health clinician
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Referrals to behavioral health clinicians for SBIRT
Time Frame: During the 2 year intervention period
|
Patients seen by behavioral health clinicians in both intervention arms will be determined via appointment codes
|
During the 2 year intervention period
|
|
Brief Interventions
Time Frame: During the 2-year intervention period
|
Brief Interventions will be documented in the Electronic Health Record via administrative Z-codes within 1 week of the index screening visit.
|
During the 2-year intervention period
|
|
Referrals
Time Frame: During the 2-year intervention period
|
Referrals to specialty treatment will be coded using the electronic referral program in the Electronic Health Records within 1 week of the Brief Intervention.
|
During the 2-year intervention period
|
|
Specialty Treatment Initiation
Time Frame: Within 2 months of the index screening visit.
|
Initiation is defined as at least 1 visit to specialty treatment (Addiction Medicine or Child & Adolescent Psychiatry).
|
Within 2 months of the index screening visit.
|
|
Specialty Treatment Engagement
Time Frame: Within 34 days of the initial specialty care initiation encounter.
|
Engagement is defined as 2 or more specialty treatment encounters.
|
Within 34 days of the initial specialty care initiation encounter.
|
|
AOD and Mental Health Diagnoses
Time Frame: within 1 year and 2 years of the index screening visit
|
Clinical International Classification of Diseases-10 AOD, depression, and anxiety diagnoses
|
within 1 year and 2 years of the index screening visit
|
|
Alcohol and other drug use
Time Frame: 1- and 2-year follow-up visits.
|
Alcohol and other drug use will be measured by the Screening to Brief Intervention (S2BI) screening tool: "In the past year, how many times have you used: alcohol, marijuana (smoked, edible, dabs), tobacco (cigarettes), vaping nicotine, vaping marijuana, other substances?"
Responses: never, once or twice, monthly, weekly or more
|
1- and 2-year follow-up visits.
|
|
Depressive symptoms
Time Frame: 1- and 2-year follow-up visits.
|
Prior two-week depression measures via the Patient Health Questionnaire-2, a validated and commonly used screener for depression: "Over the last 2 weeks how often have you been bothered by the following problems?
1)Little interest or pleasure in doing things; 2) Feeling down, depressed or hopeless?"
- Responses: not at all, several days, more than half the days, nearly every day
|
1- and 2-year follow-up visits.
|
|
Suicidality
Time Frame: 1- and 2-year follow-up visits.
|
Suicidality measured by: Have you thought seriously about killing yourself, made a plan, or tried to kill yourself?
Responses: Y/N
|
1- and 2-year follow-up visits.
|
|
Health Services Utilization
Time Frame: Within 1 year and 2 years of the index screening visit.
|
The number of inpatient and Emergency Department encounters
|
Within 1 year and 2 years of the index screening visit.
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 1951166
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.